CDH1 and diabetic kidney disease: As one of the mechanisms of development of diabetic nephropathy is endothelial to mesenchymal transition, studies show that E-cadherin levels fall with more transition and loss of endothelium and could be considered a novel biomarker of diabetic nephropathy development and progression [151].